Summary of Study ST003733

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002319. The data can be accessed directly via it's Project DOI: 10.21228/M8W245 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST003733
Study TitleProteomics and metabolomics analysis of Mongolian acupuncture therapy for type 2 diabetes mellitus with atherosclerosis
Study SummaryThe results of serum biochemical and H&E staining analysis suggest that acupuncture therapy can improve cellular inflammatory factors, kidney function, serum lipid function and upper carotid artery tissue lesions in rat of T2DM with atherosclerosis, which is an effective treatment method. In addition, we applied proteomics and metabolomics to comprehensively demonstrate that Mongolian acupuncture therapy in T2DM with atherosclerosis mainly through regulation of fatty acid metabolism.
Institute
Inner Mongolia Medical University
Last NameLi
First NameXueyong
AddressJinshan Campus, Chilechuan Dairy Development Zone, Hohhot, Inner Mongolia, China, 010110
Email1324612868@qq.com
Phone18947196075
Submit Date2025-02-07
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2025-03-04
Release Version1
Xueyong Li Xueyong Li
https://dx.doi.org/10.21228/M8W245
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR002319
Project DOI:doi: 10.21228/M8W245
Project Title:Proteomics and metabolomics analysis of Mongolian acupuncture therapy for type 2 diabetes mellitus with atherosclerosis
Project Type:Metabolomics analysis
Project Summary:The results of serum biochemical and H&E staining analysis suggest that acupuncture therapy can improve cellular inflammatory factors, kidney function, serum lipid function and upper carotid artery tissue lesions in rat of T2DM with atherosclerosis, which is an effective treatment method. In addition, we applied proteomics and metabolomics to comprehensively demonstrate that Mongolian acupuncture therapy in T2DM with atherosclerosis mainly through regulation of fatty acid metabolism.
Institute:Inner Mongolia Medical University
Department:School of Mongolian Medicine and Pharmacy
Last Name:Li
First Name:Xueyong
Address:Jinshan Campus, Chilechuan Dairy Development Zone, Hohhot, Inner Mongolia, China, 010110
Email:1324612868@qq.com
Phone:18947196075

Subject:

Subject ID:SU003865
Subject Type:Mammal
Subject Species:Rattus norvegicus
Taxonomy ID:10116
Gender:Male

Factors:

Subject type: Mammal; Subject species: Rattus norvegicus (Factor headings shown in green)

mb_sample_id local_sample_id Sample source Factor
SA407458Acp5carotid artery tissue Acupuncture
SA407459Acp4carotid artery tissue Acupuncture
SA407460Acp3carotid artery tissue Acupuncture
SA407461Acp2carotid artery tissue Acupuncture
SA407462Acp1carotid artery tissue Acupuncture
SA407463Control2carotid artery tissue Control
SA407464Control1carotid artery tissue Control
SA407465Control5carotid artery tissue Control
SA407466Control4carotid artery tissue Control
SA407467Control3carotid artery tissue Control
SA407468Mol4carotid artery tissue Model
SA407469Mol3carotid artery tissue Model
SA407470Mol2carotid artery tissue Model
SA407471Mol1carotid artery tissue Model
SA407472Mol5carotid artery tissue Model
SA407473QC1carotid artery tissue QC
SA407474QC2carotid artery tissue QC
SA407475QC3carotid artery tissue QC
Showing results 1 to 18 of 18

Collection:

Collection ID:CO003858
Collection Summary:SD male rats (SPF, 130-150 g) were randomly selected as diabetic modals of DM (fed high-sugar and high-fat diet). After 6 weeks of induction of insulin resistance, STZ injection was diluted with sterile sodium citrate buffer (0.1 mol L-1, pH 4.2) and injected into mice at a subpathogenic dose (30 mg kg-1) tail vein to induce the occurrence of diabetes. After injection, caudal vein blood was collected on day 3, day 5 and day 7 respectively, and blood glucose exceeding 16.7 mmol L-1 was successful in the modeling of diabetic rats, and unsuccessful 15 rats were excluded. Then vitamin D3 injection was given to diabetic model rats with a total dose of 6×105 U kg-1 for 3 consecutive days, which damaged the integrity of the arterial wall of the rats, increased endothelial permeability, promoted the immersion and deposition of lipids and calcium in the vascular wall, caused the overload of arterial calcium, and promoted the degeneration and calcification of smooth muscle cells. Rats in the diabetic model group are continued to receive a high-fat diet for 4 weeks. At the end of the experiment, all rats were sacrificed, and the upper carotid artery tissue was sent for examination.
Collection Protocol Filename:Experimental_Protocol_for_Harvesting_Carotid_Artery_from_Rats.pdf
Sample Type:carotid artery tissue

Treatment:

Treatment ID:TR003874
Treatment Summary:the upper carotid artery tissue of about 1 cm long was quickly taken, rinsed with normal saline, frozen with liquid nitrogen and stored at -80 ℃ until metabolite detection

Sample Preparation:

Sampleprep ID:SP003871
Sampleprep Summary:Samples were weighed before the extraction of metabolites and dried lyophilized were ground in a 2 mL Eppendorf tube containing a 5 mm tungsten bead for 1 min at 65 Hz in a Grinding Mill. Metabolites were extracted using 1 mL precooled mixtures of methanol and water (v/v,4:1) and then placed for 1 h ultrasonic shaking in ice baths. Subsequently, the mixture was placed at -20°C for 1 h and centrifuged at 14,000 g for 20 min at 4°C. The supernatants were recovered and concentrated to dryness in vacuum.

Combined analysis:

Analysis ID AN006124 AN006125
Analysis type MS MS
Chromatography type Reversed phase Reversed phase
Chromatography system Shimadzu Nexera X2 Shimadzu Nexera X2
Column Waters ACQUITY UPLC HSS T3 (100 x 2.1 mm, 1.8 μm) Waters ACQUITY UPLC HSS T3 (100 x 2.1 mm, 1.8 μm)
MS Type ESI ESI
MS instrument type Orbitrap Orbitrap
MS instrument name Thermo Q Exactive Plus Orbitrap Thermo Q Exactive Plus Orbitrap
Ion Mode POSITIVE NEGATIVE
Units Peak area Peak area

Chromatography:

Chromatography ID:CH004651
Instrument Name:Shimadzu Nexera X2
Column Name:Waters ACQUITY UPLC HSS T3 (100 x 2.1 mm, 1.8 μm)
Column Temperature:40℃
Flow Gradient:The gradient was 0% buffer B for 2 min and was linearly increase to 48% in 4 min, and then up to 100% in 4 min and maintained for 2 min, and then decreased to 0% buffer B in 0.1 min, with 3 min re-equilibration period employed.
Flow Rate:0.3 mL/min
Solvent A:100% Water; 0.1% formic acid
Solvent B:100% acetonitrile (ACN)
Chromatography Type:Reversed phase

MS:

MS ID:MS005830
Analysis ID:AN006124
Instrument Name:Thermo Q Exactive Plus Orbitrap
Instrument Type:Orbitrap
MS Type:ESI
MS Comments:The electrospray ionization (ESI) with positive-mode and negative mode were applied for MS data acquisition separately. The instrument was set to acquire over the m/z range 70-1050 Da for full MS. The full MS scans were acquired at a resolution of 70,000 at m/z 200, and 17,500 at m/z 200 for MS/MS scan. The maximum injection time was set to for 100 ms for MS and 50 ms for MS/MS. The isolation window for MS2 was set to 2 m/z and the normalized collision energy (stepped) was set as 20, 30 and 40 for fragmentation. The raw MS data were processed using MS-DIAL for peak alignment, retention time correction and peak area extraction.
Ion Mode:POSITIVE
  
MS ID:MS005831
Analysis ID:AN006125
Instrument Name:Thermo Q Exactive Plus Orbitrap
Instrument Type:Orbitrap
MS Type:ESI
MS Comments:The electrospray ionization (ESI) with positive-mode and negative mode were applied for MS data acquisition separately. The instrument was set to acquire over the m/z range 70-1050 Da for full MS. The full MS scans were acquired at a resolution of 70,000 at m/z 200, and 17,500 at m/z 200 for MS/MS scan. The maximum injection time was set to for 100 ms for MS and 50 ms for MS/MS. The isolation window for MS2 was set to 2 m/z and the normalized collision energy (stepped) was set as 20, 30 and 40 for fragmentation. The raw MS data were processed using MS-DIAL for peak alignment, retention time correction and peak area extraction.
Ion Mode:NEGATIVE
  logo